One-Doctor sedation could speed up heart treatment
NCT ID NCT07571447
First seen May 16, 2026 · Last updated Jun 22, 2026 · Updated 5 times
Summary
This study compares two ways to sedate patients during a heart scan and electric shock treatment for atrial fibrillation. Currently, a cardiologist gives mild sedation for the scan, but an anaesthesiologist must give stronger sedation for the shock, causing delays. Researchers want to see if a cardiologist can safely handle both steps using midazolam alone. The trial will include 220 adults in Denmark and measure how quickly patients go home, treatment success, side effects, and costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gødstrup Hospital
Herning, Central Jutland, 7400, Denmark
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Randers Regional Hospital
Randers, Central Jutland, Denmark
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
midazolam
What this could lead to
If this works, it could mean faster treatment and shorter hospital stays for people with atrial fibrillation needing a heart scan and shock.
What could go wrong
This is a phase 4 trial with 220 people, so results may not apply to everyone. Midazolam may not provide enough sedation for some patients, requiring extra help.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.